Literature DB >> 20650169

The EC/HO international validation study on alternatives to the draize eye irritation test.

M Balls1, P A Botham, L H Bruner, H Spielmann.   

Abstract

This is the final report of the Management Team for a European Commission/British Home Office (EC/HO) validation study on alternatives to the Draize eye irritation test. The principal goal of the study was to establish whether one or more of nine non-animal tests could be used to replace the Draize test for all severely irritating materials (or those belonging to specific classes) or the animal test completely for chemicals with or without regard to chemical class. Sixty chemicals were independently selected, coded and supplied, then the data obtained in 37 laboratories were analysed independently. The results of comparisons between 27 alternative test index scores and the Modified Maximum Average Scores (MMASs) obtained in the Draize eye test were compared. Tables of results showing Pearson's product moment correlation coefficients and Spearman's rank coefficients for each laboratory are provided, and correlation matrices of alternative test index scores among the different groups of laboratories are shown for each endpoint. Scatterplots are provided, in which the alternative test scores obtained by the lead laboratories for the nine tests are plotted against the MMAS for the full set of chemicals and 12 surfactants. It is concluded that, with the possible exception of predicting the irritancy of surfactants, none of the nine tests met any of the four performance targets. Possible reasons for this outcome are discussed.

Entities:  

Year:  1995        PMID: 20650169     DOI: 10.1016/0887-2333(95)00092-5

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  6 in total

Review 1.  Validating and troubleshooting ocular in vitro toxicology tests.

Authors:  Frank A Barile
Journal:  J Pharmacol Toxicol Methods       Date:  2010-01-22       Impact factor: 1.950

2.  Low potential ocular irritation of arginine-based gemini surfactants and their mixtures with nonionic and zwitterionic surfactants.

Authors:  Montserrat Mitjans; Verónica Martínez; Pere Clapés; Lourdes Pérez; M Rosa Infante; M Pilar Vinardell
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

Review 3.  Same-chemical comparison of nonanimal eye irritation test methods: Bovine corneal opacity and permeability, EpiOcular™, isolated chicken eye, ocular Irritection®, OptiSafe™, and short time exposure.

Authors:  Stewart Lebrun; Linda Nguyen; Sara Chavez; Roxanne Chan; Debby Le; Minh Nguyen; James V Jester
Journal:  Toxicol In Vitro       Date:  2020-12-19       Impact factor: 3.500

Review 4.  Cosmetics Europe compilation of historical serious eye damage/eye irritation in vivo data analysed by drivers of classification to support the selection of chemicals for development and evaluation of alternative methods/strategies: the Draize eye test Reference Database (DRD).

Authors:  João Barroso; Uwe Pfannenbecker; Els Adriaens; Nathalie Alépée; Magalie Cluzel; Ann De Smedt; Jalila Hibatallah; Martina Klaric; Karsten R Mewes; Marion Millet; Marie Templier; Pauline McNamee
Journal:  Arch Toxicol       Date:  2016-03-21       Impact factor: 5.153

5.  Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop.

Authors:  Xurxo García-Otero; Victoria Díaz-Tomé; Rubén Varela-Fernández; Manuel Martín-Pastor; Miguel González-Barcia; José Blanco-Méndez; Cristina Mondelo-García; Maria A Bermudez; Francisco Gonzalez; Pablo Aguiar; Anxo Fernández-Ferreiro; Francisco J Otero-Espinar
Journal:  Pharmaceutics       Date:  2021-01-23       Impact factor: 6.321

6.  Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model.

Authors:  Yulia Kaluzhny; Helena Kandárová; Laurence d'Argembeau-Thornton; Paul Kearney; Mitchell Klausner
Journal:  J Vis Exp       Date:  2015-08-23       Impact factor: 1.355

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.